OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Treatment-Related Interstitial Lung Disease

home / insights / treatment-related-interstitial-lung-disease

Through the lens of multidisciplinary management in breast cancer, experts share practical insight on the identification and management of interstitial lung disease.

Advertisement
Managing Breast Cancer: Who’s Involved in Multidisciplinary Care?

EP. 1: Managing Breast Cancer: Who’s Involved in Multidisciplinary Care?

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
August 25th 2021
Managing Breast Cancer: Collaboration Throughout the Treatment Journey

EP. 2: Managing Breast Cancer: Collaboration Throughout the Treatment Journey

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
August 25th 2021
Difference in Breast Cancer Outcomes With Multidisciplinary Care

EP. 3: Difference in Breast Cancer Outcomes With Multidisciplinary Care

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 1st 2021
Multidisciplinary Care in BC: How Best to Communicate Patient Information

EP. 4: Multidisciplinary Care in BC: How Best to Communicate Patient Information

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 1st 2021
Challenges in the Multidisciplinary Management of Breast Cancer

EP. 5: Challenges in the Multidisciplinary Management of Breast Cancer

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 8th 2021
Multidisciplinary Care for a Patient With Metastatic HER2+ Breast Cancer

EP. 6: Multidisciplinary Care for a Patient With Metastatic HER2+ Breast Cancer

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 8th 2021
Advertisement
Breast Cancer Management: Monitoring Patients for ILD

EP. 7: Breast Cancer Management: Monitoring Patients for ILD

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 15th 2021
Optimal Management of ILD in Patients With Breast Cancer

EP. 8: Optimal Management of ILD in Patients With Breast Cancer

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 15th 2021
Practical Considerations for Identifying and Managing ILD in Breast Cancer

EP. 9: Practical Considerations for Identifying and Managing ILD in Breast Cancer

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 22nd 2021
Multidisciplinary Care in Breast Cancer: Take-Home Messages

EP. 10: Multidisciplinary Care in Breast Cancer: Take-Home Messages

Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center
September 22nd 2021
Experts on ILD

EP. 11: An Overview of Interstitial Lung Disease

Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center;Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute
September 24th 2021
Experts on Interstitial Lung Disease

EP. 12: Identifying ILD: Symptomology and Work-Up

Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute;Mark Pegram, MD, Stanford Women's Cancer Center
September 24th 2021
Advertisement
Experts on Interstitial Lung Disease

EP. 13: Identifying Risk Factors for Interstitial Lung Disease

Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center;Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute
October 1st 2021
Experts on Interstitial Lung Disease

EP. 14: Monitoring Patients for Interstitial Lung Disease

Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center;Mark Pegram, MD, Stanford Women's Cancer Center;Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute
October 1st 2021
Experts on Interstitial Lung Disease

EP. 15: Approaching the Management of Interstitial Lung Disease

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy, MD
October 8th 2021
Experts on Interstitial Lung Disease

EP. 16: Managing ILD: Taking Therapeutic Class Into Account

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy, MD
October 8th 2021
Experts on Interstitial Lung Disease

EP. 17: Optimizing the Management of ILD: Steroids, Therapy Cessation, and Dose Modification

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy, MD
October 15th 2021
Experts on Interstitial Lung Disease

EP. 18: Role of Bronchoscopy in Identifying and Managing ILD

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy, MD
October 15th 2021
Advertisement
Experts on interstitial lung disease

EP. 19: Understanding the Risk-Benefit Comparison of Agents That May Cause ILD

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy
October 22nd 2021
Experts on interstitial lung disease

EP. 20: Multidisciplinary Care in ILD Management: Role of a Pulmonologist

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy, MD
October 22nd 2021
Experts on interstitial lung disease

EP. 21: Optimizing the Management of ILD: Take-Home Messages

Mark D. Pegram, MD;Charles Powell, MD;Joyce A. O'Shaughnessy
October 29th 2021

Latest Conference Coverage

Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777
© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact